A live AI chatbot trained on his 244 SKUs + 2,531 Judge.me reviews + every Certificate of Analysis batch, deployed to a real URL inside 7 days. Paired with a founder-authority pitch deck for Richard's medtech-to-cannabis story and 8 ready-to-send podcast / trade press outlet pitches.
All shipped before Richard signs anything. His to keep either way.
Want all 16 wedge candidates ranked, with hybrids + gold/gems? → budtender-wedges.pages.dev (internal only - 5,853 words, 16 wedges scored across 6 dimensions, 6 hybrid stacks, 5 alternative pitch framings, 29 gold/gems)
budtender-brain.pages.dev| Asset | Live URL | Status | Audience |
|---|---|---|---|
| Master deck (Tuesday leader) | budtender-deck.pages.dev | Live v1 | Forward-safe to Richard |
| Interactive chatbot (4 branches) | budtender-mockup.pages.dev | Live | Forward-safe |
| 5-sec auto-loop theatre chatbot | budtender-mockup-theatre.pages.dev | Live v1 | Forward-safe |
| Website rebuild ("the flex") | budtender-site.pages.dev | Live v1 | Forward-safe |
| Council strategy synthesis | oleo-council.pages.dev | Live | Internal only |
| Oleo audit (already with Richard) | oleo-audit.pages.dev | Live | Already forwarded |
| This Strat hub | budtender-strat.pages.dev | Live v1 | Internal only |
| Oleo Strat hub | oleo-strat.pages.dev | Building | Internal only |
| 5-variant landing page (toggle) | budtender-designs.pages.dev | Sat | Forward-safe |
| 12-page core website | budtender-full.pages.dev | Sat | Forward-safe |
| Live Budtender Brain (the wedge) | budtender-brain.pages.dev | Sun-Mon | Forward-safe |
| Constellation orb hub | budtender-orb.pages.dev | Sun | Forward-safe |
| Doc | GitHub URL | Status |
|---|---|---|
| Full Budtender folder | /oleo/budtender/ | Active |
| Tomas call lead brief | tomas-call-lead-brief.md | Needs discovery rewrite |
| Richard insights v1 | insights-v1.md | Done |
| Business family map | business-family-map.md | Done |
| OOB ideas catalogue (62) | oob-ideas-catalogue.md | Done |
| OOB v2 supplement (25 more + wedge) | oob-ideas-v2-supplement.md | Done 2026-05-08 |
| Deep audit v1 | full-audit-v1.md | Done |
| AI deep audit (50 queries x 4 engines) | ai-audit-deep-v1.md | Done |
| Competitors IE+UK v1 (10+10) | competitors-ie-uk-v1.md | Done v1 |
| Competitors mega-table v2 (15 cols) | competitors-ie-uk-v2-mega.md | Subagent running |
| Path evaluation (8 paths) | path-evaluation-v1.md | Done |
| Personas v1 (7 archetypes) | personas-v1.md | Reddit backfill running |
| Master deck brief | master-deck-brief.md | Done |
| Status update for the boys | UPDATE-2026-05-07.md | Done |
| Cannabis market deep dive (IE+UK+EU) | market-dive-v1.md | Subagent running |
| Council comparisons (13 runs + synthesis) | /oleo/council-comparisons/ | Done |
Top 10 IE + Top 10 UK with 15-column scoring matrix (SEO, ads, website, CRO, speed, mobile-vs-desktop, AI citation, schema, CoA visibility, founder depth, monthly SEO spend estimate, etc.) is being built right now (subagent running). Will replace this section once it lands.
| Competitor | Country | Why they matter | Where they're weak |
|---|---|---|---|
| Dr. Hemp Me (drhempme.ie) | IE | Content + reviews leader, schema present, trust-tier IE CBD brand | No HHC/HHCP/THCP coverage. Founder less prominent than Richard could be. |
| Little Collins (littlecollinscbd.com) | IE | Physical retail entity, strong NAP signals | Smaller catalogue, weaker on novel cannabinoids, no CoA QR play. |
| HiddenCBD (hiddencbd.com) | IE | Only direct novel-cannabinoid peer in IE | Compliance posture thin, no founder credibility play. |
| Provacan (provacan.co.uk) | UK | UK CBD market leader, heavy schema, deep content layer, brand authority | No HHC line, slow on novel-cannabinoid trends, conservative founder presence. |
| HempHash (hemphash.co.uk) | UK | Broad flower volume, fast on trends | Weak compliance posture, vague CoA practice, no founder. |
| BudMother (budmother.com) | UK | Direct novel-cannabinoid peer, the closest UK analogue to TheBudtender | Wild-West feel, no trust tier, no founder, weak schema. |
Pending mega-table v2 Will be filled with concrete monthly-spend estimates for Provacan, Dr Hemp Me, BudMother once the Doctor-level analysis subagent returns. Expected range: GBP 5-15k/month for Provacan-tier. This is the price-anchor evidence Tomas uses on Tuesday's discovery call.
budtender-site.pages.devFor each of the 12 discovery questions: what to listen for, what should set off alarm bells, and the immediate next move on signal. Collapsed by default. Expand the ones Tomas is least sure about.
| Good answer | "60-70% IE, 25-30% UK, single-digit EU." Concentrated, shippable, regulator-mappable. |
| Concerning | "Honestly we do not break it out" or "we ship to 40 countries roughly evenly." No analytics maturity = onboarding pain. |
| Next move on signal | If concentrated: lock pillar weighting Tuesday. If unknown: include "data layer audit" as scope item 1 in the Tue 20 close deck. |
| Good answer | He names 3 revenue + 3 margin and they overlap on 1-2 SKUs. Means he reads his P&L. |
| Concerning | "It depends" or he names HHC SKUs as top revenue. HHC = revenue cliff incoming, must reframe today. |
| Next move on signal | Feature his named margin SKUs in the chatbot demo. If HHC reliance, escalate "regulatory transition content engine" framing. |
| Good answer | "Around 30-40% repeat, subscription is 8-12% of revenue and growing." Healthy retention, room to grow. |
| Concerning | "Maybe 15%" or "we do not run subscriptions." Acquisition trap; CAC will eat margin. |
| Next move on signal | Below 25% = lead the Tue 20 close deck with retention math, not acquisition math. Sub-launch becomes Pillar 2 anchor. |
| Good answer | Specific channel claims with numbers. "Email is doing 18% of revenue, social does nothing for sales but builds trust." |
| Concerning | "Everything is fine" (defensive) or "Nothing is working" (despair, hard to sell to). |
| Next move on signal | If defensive: probe softer with "if you could fix one thing first, what would it be?" If despair: lead Tue 20 with quick-win calendar (Klaviyo flows + schema in Week 1-2). |
| Good answer | "Klaviyo is on, welcome + abandoned cart live, ~25% open rate, 12-15% of revenue." Mature. |
| Concerning | "We use Mailchimp" or "we have it but never set up flows." Either platform-migration tax or quick-win paradise. |
| Next move on signal | Mature = pivot Pillar 2 to SMS + Judge.me review velocity. Bare = Week 4 demo is the welcome-flow lift, easiest visible win. |
| Good answer | Names 1-2 agencies + a freelancer. Reveals price ceiling and framing rivals. |
| Concerning | "Just you" (we are the only bid, can lose to no-decision) or "five agencies" (commodity bake-off, hard to win on price). |
| Next move on signal | Solo bid: pivot to discovery-then-deepen, treat Tuesday as alignment not auction. Five bidders: weaponise wedge offer immediately, escape commodity frame. |
| Good answer | Specific event: "Allwright in autumn" / "Tilray IE in Q4" / "Olio launch when MCAP shifts." |
| Concerning | "No real urgency" (kills momentum) or "yesterday" (panic, churn risk). |
| Next move on signal | Specific event: anchor Tue 20 close deck on the date. No urgency: insert artificial urgency frame ("Tilray is moving"). Panic: deploy wedge same week. |
| Good answer | "Probably 3-5k a month range." Aligned, easy close. |
| Concerning | "Under 2k" (mismatch) or refuses to share ("you tell me a number"). |
| Next move on signal | Aligned: lock 4-5k Tue 20. Mismatch: re-anchor on Provacan 8-15k + offer 3k Phase 1-only tier. Refuses: do not press, walk Doctor-spend slide harder. |
| Good answer | "Real, board introductions in Q3, MCAP supply chain pilot in Q4." Tier 1 strategic platform value. |
| Concerning | "It is on the radar" (vapour) or "totally aspirational." Drop the rail framing. |
| Next move on signal | Real: bake Celadon-readiness into Tue 20 close deck as bonus track. Aspirational: never mention again, redirect to Oleo back-pocket as the platform play. |
| Good answer | "Allwright publication, expected autumn-winter." Concrete dependency we can plan around. |
| Concerning | "When the time is right" (no plan) or "we already started" (we are behind). |
| Next move on signal | Allwright: trigger Oleo readiness package as wedge B. Already started: ask "who is doing it now?" and pivot to rescue framing. |
| Good answer | "Shirley owns dev, you advise. She ships." Lower-effort retainer, advisory model. |
| Concerning | "Shirley is too busy" (we own dev, scope expands) or "Shirley wants to vet everything" (gatekeeper risk). |
| Next move on signal | She ships: drop scope to advisory + EUR 500-1k off retainer. We ship: lock EUR 4-5k + need access on Day 1. Gatekeeper: bring Shirley into Tue 20 close call directly. |
| Good answer | Names a specific failed agency or tactic with a reason. "Hired X agency, generic content, wasted 6k." |
| Concerning | "Never tried anything" (rare in cannabis, suspicious) or "long story, do not get me started" (unhealed wound, tread carefully). |
| Next move on signal | Specific failure: name our anti-pattern explicitly in Tue 20 deck ("not generic content, batch-CoA-grounded content"). Wound: let him vent, do not interrupt, then mirror back. |
Each slide gets an opener (what Tomas says first, in blockquote), a transition out, and a time budget. Total target: 35-40 minutes presentation, 30-40 minutes Q&A + discovery questions, 10 minutes close-the-loop.
"Richard, Shirley, thanks for the time. John, good to have you on. We have put together a lot, findings from a deep audit, a 50-query AI ranking probe across 4 engines, a top-10 IE plus UK competitor scoring matrix, and the strategy paths we evaluated. Today is a discovery call, so let's walk it, ask each other questions, and we will firm up the proposal next Tuesday."
Transition: "Let's start with what we hear from you, then we will show what we found."
"Big thing first. We saw the regulatory shift on HHC across IE, NL, FR, DE, SE in the last 90 days. Ireland banned it July last year, Netherlands put it on heroin schedule three months ago. We assume you are already on top of it. The reason we are showing you what we are showing today is that it actually strengthens the case for the SEO and AI ranking work, not weakens it. Sound right?"
Transition: "Did we read your situation right? [pause for nod]. Cheers, let's show you what we found."
"Three numbers from the audit. 244 products, 0 with descriptions optimised for search. 2,531 Judge.me reviews, 0 surfaced as schema. 0 indexed blog posts. Read this as a strength. The hard parts, you have done. Phase 1 is the layer that makes it findable and citable."
Transition: "So that is your starting line. Next: where you sit against the competitor set."
"Top 10 IE, top 10 UK. Two gaps that matter. One, no Irish hemp ecom owns the knowledge layer. Two, the UK novel-cannabinoid market has 30 plus shops, no clear trustworthy one. You can take both slots. Compliance, age-gate, CoA, you already beat most of them. Compliance is a strength, not a tax."
Transition: "Now the AI side, where we ran a deeper probe. Donal, this is your slide."
[Tomas, hand off]: "Donal, this is your slide. Walk Richard through what we actually found across the four AI engines."
Transition (after Donal hands back): "Cheers Donal. So that is where you stand today. Here is what we would do about it."
"Ten ways across SEO, AI ranking, content, owned audience, and entity work. Six are easy or medium where we know exactly what to ship. Two are harder and worth the time. One is on hold pending regulatory clarity. The chatbot is the demo on slide 8."
Transition: "Now, how that lands across 90 days."
"Three pillars, twelve weeks. Week 4 acceptance: schema deployed, top 50 SKUs descriptions live, Klaviyo welcome plus abandoned cart on. Week 12: full content layer, AI citation lift measured against today's 12% baseline. Deliverables we own, not outcomes we promise."
Transition: "Before we get to investment, one slide on what we evaluated and rejected."
"Eight strategy paths considered. Three locked, two rejected outright (Paid Google plus Meta both ban cannabinoid retail), three flagged as Phase 2. We are not pitching what we cannot ship. The chatbot, that is next."
Transition: "Donal, you are taking the chatbot demo."
[Tomas, hand off]: "Donal is going to show you the chatbot we mocked up. It is the conversion layer for everything we just walked through."
Transition (after Donal hands back): "Tomas, want to walk Richard through what we would recommend on investment?"
"Investment-wise, we are looking at the EUR 3 to 5 thousand a month range. We will firm up the exact tier next Tuesday once we have heard your priorities. For context, here is what your top competitors are actually spending. Provacan 8-15k, Dr Hemp Me 4-7k, BudMother 2-5k. Where we would anchor for you: 4 to 5 thousand a month, top of Tier 2, matching Dr Hemp Me's IE leader spend."
Transition: "[Pause for reaction, do not fill silence]. We are not asking for a yes today. What we want to hear is whether the shape of this looks right."
"You may be wondering, could John just run this directly. The honest answer: John as your relationship lead, OO retains the toolchain underneath. Both. The bonus structure aligns John with your retention plus traffic targets, not ours."
Transition: "One more thing before we wrap up the walkthrough. Donal, the Oleo bonus track."
[Tomas, hand off]: "Donal, this is yours. The Oleo bonus track."
Transition (after Donal hands back): "Right, last slide. Defined finish."
"What we would like to do is regroup next Tuesday, the 20th of May. Same time. We come back with a sharper plan tuned to what you have told us today, the locked tier within the 3-5k range, and a defined start date for the work. Sound right? Tuesday 20 May, same hour, do you have it?"
Transition: "[Wait for confirmation]. Brilliant. We will send the calendar invite plus a one-page recap of today by Wednesday."
| Objection | Rebuttal (2 lines) |
|---|---|
| "We just need SEO." | "Cannabis SEO without AI ranking gets you found by Google's old crawl. Today, 30%+ of brand-research queries happen inside ChatGPT and Perplexity, where Google ranking is irrelevant. We build the layer that wins both. SEO is half the work; AI citation is the other half." |
| "How is this different from the 5 other agencies pitching me?" | "They are quoting tasks. We have already shipped the assets, free, before you signed anything. The chatbot is live. The audit is done. The competitor matrix is built. The wedge offer is yours to keep regardless. Most agencies talk about what they will do; we show what we already did." |
| "Can John run this on the Oleo side instead?" | "John can run the relationship layer; the toolchain (DataForSEO, schema deploy, AI ranking probe, Klaviyo flows) is OO's. John as freelancer + OO toolchain + bonus alignment = stronger than John alone. We have already structured it that way." |
| "Send me a proposal and I will review with Shirley." | "Happy to. We would prefer Shirley on the Tue 20 call so she can challenge the technical scope live. 30 minutes of her time saves a week of email. Want us to invite her?" |
| "What if it doesn't work?" | "Cannabis SEO has 3-6 month timelines, that is honest. Week 4 acceptance is real (schema, descriptions, Klaviyo flows live). Week 12 is the citation lift measurement against today's 12% floor. If we miss Week 4 deliverables, we fix on our time. If we miss Week 12 citation lift, we extend the engagement at no extra cost until it lands." |
| "Why EUR 4k+ when others quote 2k?" | "At 2k, you get tasks. At 4k, you get a system. HiddenCBD spends 1-3k and has the smallest organic footprint of any IE novel-cannabinoid peer; there is a reason. Provacan spends 8-15k. Dr Hemp Me 4-7k. We are anchored against the leaders, not the laggards." |
| "I'm waiting for Allwright before deciding on Oleo." | "Smart. Oleo is not what we are pitching today; Budtender is. The Oleo work we showed on slide 11 is yours regardless, ready when MCAP shifts. Budtender does not depend on Allwright; the regulatory transition content engine works in any HHC scenario." |
| "We work with Bedrocan via different rails - won't that conflict?" | "Bedrocan is your supply moat on the medical side; Budtender is hemp ecom under separate jurisdiction. The two never share authorship voice or product claims (Shirley editorial gatekeeper). No conflict, full firewall, that is the architecture." |
Tomas cue: "Donal, this is your slide. Walk Richard through what we actually found across the four AI engines."
Donal first 30s: "Cheers. So we ran 50 queries across ChatGPT, Perplexity, Google AI Overviews, and Claude. Net citation rate for TheBudtender today is 12% across the 200 query-engine pairs. The Irish queries are the worst; you are invisible on 'CBD oil Ireland' across all 4 engines. The UK novel-cannabinoid queries are where we see the lift potential, no clear winner there."
Handback: "Tomas, want to take it from there?"
Tomas cue: "Donal is going to show you the chatbot we mocked up. It is the conversion layer for everything we just walked through."
Donal first 30s: "Sharing screen. This is at budtender-mockup.pages.dev, live URL, you can open it after the call. Watch what happens when I ask 'I cannot sleep, recommend something': it surfaces a CBN product, shows the actual lab CoA, gives a dose suggestion based on body weight, then offers the add-to-cart. Three taps from question to checkout."
Handback: "Tomas, want to walk Richard through what we would recommend on investment?"
Tomas cue: "Donal, this is yours. The Oleo bonus track."
Donal first 30s: "By the way, the same depth of work we did for Budtender, we did for Oleo too. Side project, just so we would be ready when Allwright lands. We mapped the 22-consultant prescriber pool, scored 25 medical-cannabis competitors, drafted a 7-day regulatory readiness package. Tilray is coming. We have already built what Oleo needs to lock the 6-month window post-publication. Not pitching this today. Yours for free either way."
Handback: "Hand back to Tomas for slide 12."
Tomas cue: "Donal, that's yours."
Donal first 30s: Whatever the question is. If it is about schema, give the 2-line answer. If it is about Shopify, name the API. If it is about something we have not planned for, say "good question, let me come back to that on the recap email Wednesday with the actual data."
Handback: "Tomas, where were we?"
| Trigger | What Tomas does |
|---|---|
| Richard goes quiet for >8 seconds | Do NOT fill the silence. Count to 10 internally. If still silent: "Richard, want me to keep going or pause for a question?" Most likely he is processing the price anchor; let him. |
| Richard challenges a specific number | "Fair challenge. Let me show you the source." Pull up budtender-strat.pages.dev in tab 4. Reference the relevant section (audit-v1, AI deep audit, or competitor mega-table). If the number is from the deck, point to slide footnote. |
| Richard asks "have you shipped this for cannabis before?" | "Honest answer, not for cannabis specifically. We have shipped the same stack (schema, AI citation lift, Klaviyo flows, founder entity work) for 9 retainer clients in roofing, dental, moving, ecom. The cannabis layer we have built bespoke for you. Everything you saw today, the audit, the competitor matrix, the chatbot, the website rebuild, that is custom for your category. Most agencies pitching cannabis are pitching a generic ecom stack." |
| Shirley hijacks the call on tech detail | Do NOT try to answer. "Shirley, that is a great technical question. Donal will take it." Donal answers in 30-60 sec. Tomas takes back: "Right, where were we." Pivot back to the slide flow. |
| Richard mentions a competitor we have not researched | "Good name to add. We have 20 in the matrix; if [name] is not in there yet, we will fold them in for the Tuesday 20 close deck. Quick context, what makes them a threat, in your view?" Capture verbatim. Add to competitor matrix v3 same day. |
| Richard pushes back on the wedge offer ("free is suspicious") | "Fair. The honest reason: it costs us 2-3 days to build, gives us a working asset to learn your catalogue, and removes the decision pressure on Tuesday. You take it, we take the learning. Either way you keep the chatbot." |
| Richard mentions a regulator (HPRA, ASAI, Trading Standards) by name | Listen. Note exactly what he says. Acknowledge: "That is the conversation we want to have, regulator-aware. We will fold the specific [HPRA/ASAI/etc] frame into the Tuesday 20 close deck." |
| Call goes long (past 75 minutes) | At minute 75: "Richard, conscious of your time, want me to wrap or push to 90?" His answer tells you everything. If "wrap": land slide 12 in 2 min. If "push": you have permission, finish properly. |
| Richard says "I have to jump" | Do NOT panic. "Got it. Let's land the only thing that matters: Tuesday 20 May, same hour, regroup with a sharper plan?" Get the calendar yes. Send recap email within 1 hour. |
Why: his own catalogue size. Says we did our homework. Says we counted, not estimated.
Where to drop it: slide 2 ("244 products, 0 with descriptions") and the wedge offer pitch ("trained on his 244 SKUs").
Why: his unmilked owned-asset. Say it twice on the call. He has not heard anyone use this number with him before.
Where to drop it: slide 2 ("2,531 reviews, 0 surfaced as schema") and slide 5 (10 ways, way #4 = review schema deploy).
Why: the Doctor-level competitor SEO spend anchor. This single number reframes our 4-5k from "expensive" to "well below market leader."
Where to drop it: slide 9 (investment), and again if he objects to price ("Provacan is 8-15. We are anchoring at 4-5, which is Dr Hemp Me's tier, not Provacan's").
22 prescribing consultants (Oleo prescriber pool, IE medical cannabis). Drop on slide 11 only. Says we know the medical side too, not just hemp ecom.
| Name | Why drop it | Where on the call |
|---|---|---|
| Bedrocan | His medical supply moat. Saying it on the call signals we mapped his actual supply chain, not just his Shopify front-end. | Slide 11 (Oleo back-pocket) or in answer to a supply-chain question. |
| Curaleaf Belfast | His cross-border risk. NI cannabis facility, EU-side proximity threat. Says we see what he sees about jurisdiction risk. | Slide 3 (competitor set, when discussing UK threat tier) or answer to "what about UK competition?" |
| Allwright Review | The Oleo trigger event. Names the regulatory unlock he is waiting for. Most agencies do not know this is the dependency. | Slide 11 (Oleo back-pocket). "When Allwright lands, you can move on Olio.com. We will be ready." |
| Tilray (bonus) | The big incumbent threat to IE medical. Drop only if discussing market timing. | Slide 11 only, if Richard asks "what is the pressure to move on Oleo?" |
| Celadon Pharmaceuticals (bonus) | Richard's downstream rail story (his own claim). Drop ONLY if he mentions it first; do not pre-empt. | Reactive only, in response to his own mention. |
TUESDAY DISCOVERY CALL DECISION TREE
[OPENING]
|
v
Richard mentions Allwright Review on his own?
YES -> Ship Oleo readiness package within 48hr
(calendar invite for separate Oleo-only call within 7 days)
NO -> Stay on Budtender, do not pre-empt Oleo angle until slide 11
|
v
Slide 9 (investment anchor) reaction?
"Aligned" (3-5k feels right) -> Big Dawg track: lock Wedge W1+W2+W3+W7+W11
"Tight on budget" -> Bargain Wedge: W2 (perf-locked) + W14 (Reddit calendar)
"Move fast / want to start now" -> Deploy wedge offer same call, ship Mon
"Wants Shirley to vet first" -> Hand to Donal earlier on slide 6 (technical detail)
Silent / face changes -> Pause, ask "what is your reaction?"
|
v
Tilray IE entry mentioned by Richard?
YES -> Pull up early-mover urgency frame ("6-month window post-Allwright closes when Tilray lands")
NO -> Save Tilray frame for Tue 20 close deck only
|
v
Price pushback mentioned?
YES -> Re-anchor: "Provacan 8-15k, Dr Hemp Me 4-7k. We are at 4-5k, Tier 2 of leader spend."
Then offer 3k Phase 1-only tier as fallback
NO -> Hold the 4-5k anchor, move to slide 10
|
v
HHC reliance is high (mentioned in Q2)?
YES -> Pivot Pillar 1 frame to "regulatory transition content engine"
Add CBN sleep + CBG daytime + CBD gummies as new pillar focus
NO -> Pillar 1 = standard knowledge layer build
|
v
Shirley actively engaged?
YES (technical questions, challenges) -> Invite her to Tue 20 close call directly
NO (silent, observer) -> Tomas-led close, Donal supports
HOSTILE (gatekeeper, blocking) -> Identify her concern, offer separate Shirley-only tech call
|
v
[CLOSE WINDOW]
Did Richard say "Tuesday 20 May, same hour"?
YES (confirmed) -> GREEN. Send calendar invite by Wed AM.
AMBIGUOUS -> AMBER. Email Wed with 2 time options, lock by Thu.
"Need to think" -> RED. Send recap pack Wed, John follows up Fri.
"Hard pass" -> Send takeaway pack (audit + competitor + market dive). Walk away clean.
Did Tomas + Richard verbally agree on Tuesday 20 May, same hour, before the call ended?
If yes: GREEN regardless of everything else. If no: AMBER unless Richard explicitly said "no thank you," in which case RED.
| Window | Action | Owner |
|---|---|---|
| Hour 0-1 (immediately after call) | Tomas writes 5-bullet recap (what walked, what landed, what Richard pushed back on, his answers to the 12 discovery questions, what we agreed). Donal reviews. Send recap email to Richard within 60 min. | Tomas drafts, Donal reviews, Tomas sends |
| Hour 1-2 | Update post-call-debrief-2026-05-13.md in agency-deliverables with full notes: Richard's tone, body language signals, Shirley's level of engagement, John's reads. Tag GREEN / AMBER / RED. | Donal |
| Hour 2-6 | If GREEN: Stripe link drafted (NOT sent per Rule 12) + DocuSign template prepped for Tue 20 close. If AMBER: Wednesday calendar email drafted with 2 time options. If RED: takeaway pack assembled. | Donal |
| Hour 6-24 (Wednesday morning) | Calendar invite for Tue 20 May 10:00 Dublin sent. One-page recap email landed in Richard's inbox. If wedge offer was accepted: kick off 7-day Budtender Brain build immediately. | Donal sends, Tomas CCs |
| Day 1-2 (Wed-Thu) | Cleaned-up close-deck v2 draft started based on Richard's discovery answers. Personalisation per Q1-Q12 answers. Provacan/Dr Hemp Me competitor spend visualisation finalised. | Donal builds, John gives input |
| Day 3-5 (Fri-Sun) | Refinements. Donal + Tomas on Slack, John reviews. Sharper plan, locked tier (3k / 4k / 5k chosen based on Q8 answer), defined start date. | Donal + Tomas + John |
| Day 6 (Mon 19 May) | Dry run with Tomas + Donal + John on the close-deck v2. Final tweaks. Calendar reminder fires Tue AM. | All three |
| Day 7 (Tue 20 May) | Close call 10:00 Dublin. Tomas leads. Locked tier presented. Defined start date Mon 26 May. | Tomas (lead), Donal (cameo), John (relationship) |
What we build between Tue 13 discovery and Tue 20 close, conditional on what Richard tells us Tuesday. Calendar table.
| Day | Deliverable | Trigger condition |
|---|---|---|
| Wed 14 May | One-page recap email sent to Richard (post-call recap, calendar invite for Tue 20) | Always (regardless of GREEN/AMBER/RED) |
| Wed 14 May | Discovery questionnaire (4 questions Richard did not answer, sent as PDF for Shirley to fill in) | If <6 of 12 questions answered on call |
| Thu 15 May | Close-deck v2 brief (based on Richard's specific answers, swapping in his named SKUs, his named channels, his stated number) | Always |
| Thu 15 May | Personalised competitor scoring re-run (if Richard named a competitor we did not research, fold them into mega-table v3) | Conditional on Q6 / Q12 mentions |
| Fri 16 May | Live Budtender Brain MVP (real chatbot trained on 244 SKUs + 2,531 reviews + CoA index, deployed to budtender-brain.pages.dev) | If wedge accepted on Tue 13 |
| Fri 16 May | Founder-authority pitch deck v1 (Richard's medtech-to-cannabis arc) | If wedge accepted on Tue 13 |
| Sat 17 May | Close-deck v2 build complete (Donal). 12 slides, sharper plan, locked tier, defined start date. | Always |
| Sat 17 May | 8 outlet pitches drafted (Cannabis Health News, Business of Cannabis, Prohibition Partners, IMT.ie, etc) | If wedge accepted on Tue 13 |
| Sun 18 May | Stripe payment link configured (drafted, not sent per Rule 12). Tomas reviews close-deck v2. | Always |
| Sun 18 May | Constellation orb hub deployed at budtender-orb.pages.dev (rotating-rings format, Tanatsa template) | If GREEN signal from Tue 13 |
| Mon 19 May | Dry run of close call (Tomas + Donal + John, 30 min on Slack huddle). Final close-deck tweaks. | Always |
| Mon 19 May | Calendar reminder fires + tab pre-stage for Tue 20. | Always |
| # | Workstream | Status | Owner |
|---|---|---|---|
| B.1 | Deep audit on TheBudtender.com | Done | Subagent |
| B.2 | IE+UK competitor matrix v1 (10+10) | Done | Subagent |
| B.3 | Comparison tables baked into deck | Done | Me |
| B.4b | Distillation (laymans) | Done | Subagent |
| B.5 | Council 13-run matrix + SYNTHESIS | Live URL | Subagent |
| B.6 | Master call deck | Live URL | Me |
| B.7a | Static interactive chatbot | Live URL | Me |
| B.7b | 5-sec theatre chatbot | Live URL v1 | Me |
| B.10 | Website rebuild | Live URL v1 | Me |
| B.13 | Richard insights doc | Done | Subagent |
| B.14 | Business family map | Done | Subagent |
| B.17 | OOB ideas catalogue (62) | Done | Subagent |
| B.22 | AI deep audit (50q x 4eng) | Done | Subagent |
| B.24 | Personas (7 archetypes) | Reddit backfill running | Subagent |
| B.31 | Strat hub (this doc) | Live v1 | Me |
| B.33 | Competitor mega-table v2 (15 cols) | Running | Subagent |
| B.34 | Image scrape thebudtender.com | Running | Subagent |
| B.35 | Discovery-posture deck reframe | Today | Me |
| B.36 | Theatre 3 conversations + FAQs | Today | Me |
| B.37 | Static chatbot Stripe popup | Today | Me |
| B.38 | 5-design landing-page variant | Sat | Subagent + me |
| B.39 | 12-page core website (was 50) | Sat | Subagent + me |
| B.40 | Cannabis market deep dive | Running | Subagent |
| B.41 | Wedge offer + 25 more OOB | Done 2026-05-08 | Subagent |
| B.43 | Reddit-grounded persona quotes | Running | Subagent |
| B.44 | Close deck for Tue 20 May | Wed-Mon next wk | Me |
| B.16 | Brand kit / style guide | Sat | Subagent + me |
| B.21 | Constellation orb hub | Sun | Me |
| B.25 | Cross-channel ecosystem synthesis | Sun | Subagent |
| B.26 | Founder credibility deep-dive | Sat | Subagent |
| B.27 | VSL personal video | Sun-Mon (optional) | Me + Donal record |
If Budtender hemp content and Oleo MCAP content are perceived to share authorship voice (Richard signing both), it could threaten Oleo's MCAP licence directly. ASAI and HPRA may treat hemp-product founder claims as cross-contaminating regulated medical-cannabis content.
Mitigation: Shirley reviews every line of cross-property founder content before publication. Richard needs to confirm her sign-off on Tuesday's call BEFORE any founder-credibility work ships, not afterwards. Tomas surfaces this directly during slide 10/11.
Source: founder-credibility-deep-dive.md (B.26 subagent, 2026-05-08).
| # | Blocker | Owner | Action |
|---|---|---|---|
| B1 | GitHub Pro upgrade ($4/m) for branch protection on private repos | Donal | Visit github.com/settings/billing/plans, click Get Pro. I retry protection API after. |
| B2 | Tony's availability Mon EOD for the live LLM chatbot embed (B.7d) | Donal | WhatsApp Tony |
| B3 | Friday call confirm for Harvinder (Ofab + Ollie) | Donal | WhatsApp Harvinder |
| B4 | AI course access for Harvinder + James (which course exactly?) | Donal | Specify course URL/portal |
| B5 | Gemini API key fix in tools/council.py (deprecated model) | Donal/Me | 5-min fix, low priority |
| B6 | John's bonus structure (% retainer vs scaled vs milestone) | Donal | Decide before Tue 20 May close call |
Same structure for Oleo Technologies (medical cannabis, MCAP, Allwright-pending). Live at:
https://oleo-strat.pages.dev →
Updated as Tuesday's "by the way" wow-moment evidence pack solidifies. Same 14-workstream depth as Budtender per Donal's locked decision 2026-05-08.
Updated as Tomas + John feed back · Donal pastes their G-Doc edits into Claude Code Tuesday morning · Internal only · Not for client